Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2021

View Archived Issues

Sanofi begins phase II study of SAR-443122 in cutaneous lupus erythematosus

Structural basis for the design of novel suramin derivatives as SARS-CoV-2 RdRp inhibitors

Enrollment opens in phase II study of RO-7049665 in autoimmune hepatitis

Dosing begins in phase I/II study of Covigenix VAX-001 for SARS-CoV-2

FDA clears XBiotech to begin phase I/II study of XB-2001 in pancreatic cancer

Peptron and Qilu sign licensing agreement for Peptron's PAb001-ADC

Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment

FDA clears IND application for ALLO-605 for the treatment of multiple myeloma

Promising data reported from phase Ib ZUMA-19 study of lenzilumab in DLBCL

Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction

Interim results show efficacy of gene therapy RP-L201 in pediatric leukocyte adhesion deficiency I

FDA clears IND to initiate LUMINOS-103 study of PVSRIPO in patients with advanced solid tumors

BeiGene patents new PROTACs for cancer

Roche discloses MGL inhibitors

Betta Pharmaceuticals identifies IDH2 mutant inhibitors

Suzhou Ark Biopharmaceutical identifies new compounds for HBV infection

Seoul National University discloses vaccine against SFTS virus

Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19

BO-2762: a potential candidate for colorectal cancer

Researchers give preclinical details on CARG-2020, an artificial oncolytic virus for ovarian cancer

TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma

New phase III trial evaluates tafasitamab with lenalidomide and rituximab in FL and MZL

ZX-101A inhibits tumor growth by enhancing antitumor immunity

New technique casts light on stem cell differentiation

InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder

European Commission approves Epidyolex for tuberous sclerosis complex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...